Literature DB >> 8773912

Non-steroidal anti-inflammatory drugs and variceal bleeding: a case-control study.

V de Lédinghen1, P R Mannant, J Foucher, M C Perault, T Barrioz, P Ingrand, B Vandel, C Silvain, M Beauchant.   

Abstract

BACKGROUND/AIM: The aim of this case-control study was to assess the risk of bleeding from esophageal varices associated with aspirin and non-steroidal anti-inflammatory drug consumption.
METHODS: Between January 1992 and May 1994, patients admitted for bleeding from esophageal or gastric lesions related to portal hypertension were matched with a control patient of the same age and sex, who was free of gastrointestinal bleeding. A structured interview was conducted with the cases and controls to determine drug consumption during the 2 weeks preceding admission. Fifty-nine cases and 59 controls were recruited. RESULTS/
CONCLUSIONS: Use of aspirin was more prevalent among the cases than the controls (odds ratio 3.81; 95% confidence interval 1.36-11.64; p = 0.004). This difference remained significant in the subgroups of patients with a first episode of variceal bleeding (odds ratio 3.9; 95% confidence interval 1.2-13.9, p = 0.01), but was not significant in the subgroups of patients with a recurrent episode of variceal bleeding. The use of aspirin was associated with a high risk of a first episode of variceal bleeding, suggesting that patients with portal hypertension should avoid taking these drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773912     DOI: 10.1016/s0168-8278(96)80142-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

Review 1.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

2.  Anti-inflammatory drugs and variceal bleeding: a case-control study.

Authors:  V De Lédinghen; D Heresbach; O Fourdan; P Bernard; M P Liebaert-Bories; J B Nousbaum; A Gourlaouen; M C Becker; D Ribard; P Ingrand; C Silvain; M Beauchant
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

3.  Changing common sense: Anti-platelet/coagulation therapy against cirrhosis.

Authors:  Yoshihiro Ikura; Tatsuya Osuga
Journal:  World J Hepatol       Date:  2015-07-08

Review 4.  Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.

Authors:  D Jaspersen
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

5.  Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Peter W Angus; Sanjay Saran Baijal; Yogesh Kumar Chawla; Radha Krishna Dhiman; H Janaka de Silva; Saeed Hamid; Shozo Hirota; Ming-Chih Hou; Wasim Jafri; Mobin Khan; Laurentius A Lesmana; Hock F Lui; Veena Malhotra; Hitoshi Maruyama; Debendranath Guha Mazumder; Masao Omata; Ujjal Poddar; Amrinder S Puri; Praveen Sharma; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Hasnain Ali Shah; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2008-09-05       Impact factor: 6.047

6.  Gambogic acid protects from endotoxin shock by suppressing pro-inflammatory factors in vivo and in vitro.

Authors:  Jing Geng; Shuyan Xiao; Zhonghui Zheng; Siyang Song; Lianru Zhang
Journal:  Inflamm Res       Date:  2012-10-14       Impact factor: 4.575

Review 7.  [Acute upper gastrointestinal hemorrhage. Diagnosis and management].

Authors:  H Nietsch; E Lotterer; W E Fleig
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

8.  A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm.

Authors:  Bruce Allen Runyon
Journal:  Int J Hepatol       Date:  2011-10-26

Review 9.  Ascites and spontaneous bacterial peritonitis: recommendations from two United States centers.

Authors:  Vinay Sundaram; Vignan Manne; Abdullah M S Al-Osaimi
Journal:  Saudi J Gastroenterol       Date:  2014 Sep-Oct       Impact factor: 2.485

10.  Short-Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis.

Authors:  Mitchell R McGill; Laura P James; Sandra S McCullough; Jeffery H Moran; Samuel E Mathews; Eric C Peterson; Davis P Fleming; Morgan E Tripod; Joel H Vazquez; Stefanie Kennon-McGill; Horace J Spencer; Jonathan A Dranoff
Journal:  Hepatol Commun       Date:  2021-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.